Bio Preventive Medicine Corp. (TPEX:6810)
Taiwan · Delayed Price · Currency is TWD 23.85
-0.75 (-3.05%)
At close: Oct 8, 2026
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 1.18 billion as of October 9, 2026. It is the 32,638th most valuable company in the world and the 1,968th biggest in Taiwan. Its market cap has decreased by 0.63% in one year.
Market Cap
1.18B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,968 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 1.18B, an increase of 65.87%. That is a compound annual growth rate of 10.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.18B | 1.92% |
| Dec 31, 2025 | 1.16B | -22.00% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
| Aug 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.42B |
| Abnova (Taiwan) | 1.37B |
| NeoCore Technology | 1.24B |
| Enimmune | 1.19B |
| Holy Stone Healthcare | 1.18B |
| GeneReach Biotechnology | 1.13B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |